BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34267019)

  • 1. [Development of Cancer Genomic Medicine in Kyushu Region and the Roles of Kyushu University Hospital as a Core Hospital for Cancer Genomic Medicine].
    Ito M; Baba E
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):873-877. PubMed ID: 34267019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation of the Cancer Genomic Medicine in the Tohoku District-Activity of Tohoku University Hospital as the Cancer Genome Medicine Core Base Hospital in Japan].
    Ishioka C
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):878-881. PubMed ID: 34267020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Role of Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
    Sunami K
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):617-621. PubMed ID: 31164495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Role of Core Hospital of Cancer Genomic Medicine and Regional Cooperation].
    Shirota H; Komine K
    Gan To Kagaku Ryoho; 2020 Aug; 47(8):1149-1152. PubMed ID: 32829345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interinstitutional Collaboration for Molecular Tumor Boards].
    Komine K; Shirota H
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):626-629. PubMed ID: 31164497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Roles of Designated Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
    Nishida T
    Gan To Kagaku Ryoho; 2018 Sep; 45(9):1223-1227. PubMed ID: 30237359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Panel Discussion - Problems in the Cancer Genomic Medicine].
    Ishioka C; Muto M; Yachida S; Shirota H; Hirasawa A; Miyagawa K; Ashizawa K; Kinoshita I; Nishihara H; Matsuura N; Sakurai A
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):1014-1017. PubMed ID: 36156030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cooperative Tasks among Cancer Genome Medicine Facilities].
    Shirota H
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):997-999. PubMed ID: 36156024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Issues of Equalization of Cancer Genomic Medicine-Focusing on the Current Status in Nagasaki Prefecture].
    Ashizawa K; Udo E; Soda M; Furusato B
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):1005-1007. PubMed ID: 36156027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current Status and Future Direction of Cancer Genomic Medicine in Japan].
    Muto M
    Gan To Kagaku Ryoho; 2020 Feb; 47(2):197-202. PubMed ID: 32381946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Roles of Cancer Consultation Centers].
    Sakamoto-Yamaguchi H
    Gan To Kagaku Ryoho; 2021 Jan; 48(1):17-21. PubMed ID: 33468716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology].
    Muto M; Kondo T; Yoshioka M; Fukuyama K; Suga J; Sato M; Masuda F; Ashida K; Mukai K; Matsumoto S; Kanai M
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):866-872. PubMed ID: 34267018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and implementation of Cancer Genomic Medicine in Japan.
    Mukai Y; Ueno H
    Cancer Sci; 2021 Mar; 112(3):970-977. PubMed ID: 33289217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infrastructure Required for Implementing Genomic Medicine and Expert Panel].
    Kanai M
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):622-625. PubMed ID: 31164496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of a System for Providing Cancer Genomic Medicine in Hokkaido-From the Standpoint of a Designated Core Hospital for Cancer Genomic Medicine].
    Kinoshita I; Kikuchi J; Ohhara Y; Amano T; Akita H
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):882-886. PubMed ID: 34267021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expert Panel Issues in Japan].
    Muto M
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):991-993. PubMed ID: 36156022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan.
    Kage H; Oda K; Muto M; Tsuchihara K; Okita N; Okuma Y; Kikuchi J; Shirota H; Hayashi H; Kokuryo T; Sakai D; Hirasawa A; Kubo M; Kenmotsu H; Akiyama N; Shinozaki-Ushiku A; Tanabe M; Ushiku T; Miyagawa K; Seto Y
    Cancer Sci; 2023 Jul; 114(7):3041-3049. PubMed ID: 37165760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kyushu Promotion Plan for the Platform of Human Resource Development for Cancer].
    Ota K; Baba E
    Gan To Kagaku Ryoho; 2022 Jun; 49(6):642-645. PubMed ID: 35799388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer genomic medicine in Japan.
    Mano H
    Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(7):316-321. PubMed ID: 32788553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.